Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.contraception.2016.04.018 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Motivations for obtaining advance provision of medication abortion in the United States: a qualitative study.
BMJ Sex Reprod Health
December 2024
Lyndon B. Johnson School of Public Affairs, University of Texas at Austin, Austin, Texas, USA.
Background: Advance provision of medication abortion, or the prescription of mifepristone and misoprostol before pregnancy occurs, is an unexplored care model aimed at expanding abortion access. We examine motivations for obtaining advance provision from the online telemedicine service, Aid Access, which supports people in the United States.
Methods: Between May and November 2023, we conducted semi-structured, in-depth interviews with 39 people who obtained advance provision between January 2022 and April 2023.
Fetal death: Expert consensus of the French College of Obstetricians and Gynecologists.
Int J Gynaecol Obstet
December 2024
Service de Gynécologie Obstétrique, CHU Charles-Nicolle, Rouen, France.
Fetal death is defined as the spontaneous cessation of cardiac activity after 14 weeks gestational age (GA). Regarding prevention of fetal death in the general population, it is not recommended to counsel or prescribe rest, aspirin, vitamin A, vitamin D, or micronutrient supplementation; systematically look for nuchal cord during prenatal screening ultrasound; or perform systematic antepartum monitoring by cardiotocography for the sole purpose of reducing the risk of fetal death. It is recommended to offer vaccination against influenza in epidemic periods and against SARS-CoV-2.
View Article and Find Full Text PDFTest or No-Test: Comparison of Medication Abortion Outcomes and Adverse Events When Forgoing Ultrasound, Laboratory Testing, and Physical Examination.
J Obstet Gynaecol Can
November 2024
Department of Family Practice, University of British Columbia, Vancouver, BC.
Objectives: This study aimed to compare demographics and clinical outcomes between patients who did not undergo investigations and those who underwent investigations before receiving a prescription for medication abortion (MA) during the first 6 months of the COVID-19 pandemic. Outcomes include success rates, adverse events, pathways to completion, and loss to follow-up rates.
Methods: We conducted a retrospective medical record review of 1452 patients presenting for MA between 23 March 2020 and 30 September 2020.
Exploring the availability and accessibility of medication abortion pills in Delhi, India: A mystery client study in community pharmacies.
Contraception
November 2024
Faculty of Health Sciences, University of Ottawa, Ottawa, ON, Canada; Collaborative for Interdisciplinary Global Abortion Research, Ottawa, ON, Canada. Electronic address:
Objectives: Although medication abortion drugs technically require a prescription in India, research suggests that they are often available directly from pharmacies. We conducted a mystery client study in the capital city of Delhi to explore the availability, accessibility, and pharmacy dispensing practices of mifepristone/misoprostol in the absence of a prescription.
Study Design: Using two predetermined client profiles-one of an unmarried woman and one of her male partner-we visited community pharmacies in different neighborhoods.
Exploring Consumer Preferences for Pharmacy Provision of Mifepristone in the Human-centered Design Discovery Phase.
Womens Health Issues
November 2024
Ci3, Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois.
Article Synopsis
- The study aimed to understand consumer preferences for obtaining mifepristone for medication abortion through a human-centered design approach involving workshops with participants who have experience with abortion care.
- Participants provided insights on key topics such as logistics, privacy, cost, pharmacist refusal, and follow-up care, highlighting their needs for specific information from different providers.
- The findings suggest a need for further research that incorporates personal experiences and storytelling methods to enhance the understanding of consumer experiences in accessing medication abortion services.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!